Work

Updated Results of Phase 1b Study of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate with Extended Durability, in wAMD, DME, and RVO

Year: 2020

Type: article

Source: Investigative Ophthalmology & Visual Science

Authors: Sunil Patel, Daniel Janer, Bryce Miller, Jason S. Ehrlich, Victor Perlroth, J. Pablo Velazquez-Martin

Institutions: Retina Research Institute of Texas, Kodiak Sciences

Language: English

Topic: Retinal Diseases and Treatments

Subfield: Ophthalmology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,850

OpenAlex ID: W3105840183

FWCI: 2.395

Cites:

Cited by: 16

Related to: 10